Results 71 to 80 of about 156,622 (181)
Patients with metastatic colorectal cancer who are ineligible for upfront metastasectomy may still become candidates for secondary metastasectomy with curative intent following response to primary chemotherapy. However, most studies dichotomize metastatic colorectal cancer into resectable and unresectable disease.
Julian W. Holch +18 more
wiley +1 more source
Two cases of multiple primary malignancies (two or more neoplasms without any relationship between them) are presented in this paper. The first case (65 years) was a male in whom follicular carcinoma of thyroid, metachronous neuroendocrine tumor of ...
Dibanur Rashid Siddiqua +3 more
doaj +1 more source
ABSTRACT Introduction Nephrogenic rests (NRs) and nephroblastomatosis (NBM) are precursor lesions for development of Wilms tumor (WT). Their association with the risk of relapse has not been properly assessed, partly due to misunderstanding of their diagnostic criteria and terminology.
Gordan M. Vujanić +5 more
wiley +1 more source
Double primary cancers registered in a tertiary care hospital: review of two cases
In our centre, among 1965 registered cancer patients between May 2011 and December 2013, we report three cases with multiple primary malignant neoplasms. One of them was excluded due to lack of data, and so we present the remaining two cases.
Mohammad Amrallah A. +2 more
doaj +1 more source
Introduction: The occurrence of two or more primary malignant neoplasms in the same person is rare. We have a case report of a 45-year-old woman with triple malignancy involving breast, ovary and uterine vault being managed at our center since 5 years ...
Mohammad Shadab Alam +2 more
core
Incidentally Detected Metachronous Malignancy in Patients of Papillary Carcinoma of Thyroid Posthigh-Dose Radioiodine Therapy. [PDF]
Mishra A +5 more
europepmc +1 more source
Does Everyone Need CEA? A Case for Selective Omission After Colorectal Cancer Resection
ANZ Journal of Surgery, EarlyView.
Matthew P. Irwin +3 more
wiley +1 more source
Liver metastasis is a key driver of immune tolerance in patients with melanoma receiving immune checkpoint inhibitor therapy. This single‐arm phase II trial prospectively investigated the efficacy and safety of co‐ablation combined with sintilimab for liver metastatic melanoma.
Lujun Shen +11 more
wiley +1 more source
© 2019 Objective: To examine the association between ovarian conservation and oncologic outcome in surgically-treated young women with early-stage, low-grade endometrial cancer.
Roman, L. D. +10 more
core +1 more source
Metachronous colorectal carcinoma.
During the period 1943-67, 903 Danish patients aged less than 40 years had colorectal carcinoma. The patients were followed up for up to 41 years and during this period 44 of 501 (9 per cent) operated on for cure developed a metachronous colorectal ...
Mellemgaard, A +2 more
core +1 more source

